Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data.
Alex E HenneyDavid R RileyMegan HeagueTheresa J HydesMatthew AnsonUazman AlamDaniel J CuthbertsonPublished in: Diabetes, obesity & metabolism (2024)
Treatment with SGLT2is in patients with HF was associated with a reduced risk of incident T2D, most strikingly in people with prediabetes.